Literature DB >> 24482501

Correcting 2 more myths regarding transplants for AML in second remission.

Robert Peter Gale1, Hillard M Lazarus.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24482501     DOI： 10.1182/blood-2013-12-541508

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT.

Authors:  Maria H Gilleece; Myriam Labopin; Bipin N Savani; Ibrahim Yakoub-Agha; Gerard Socié; Tobias Gedde-Dahl; Didier Blaise; Jennifer L Byrne; Charles Craddock; Jan J Cornelissen; William Arcese; Edouard Forcade; Charles Crawley; Emmanuelle Polge; Mohamad Mohty; Arnon Nagler
Journal:  Leukemia       Date:  2019-07-30       Impact factor: 11.528

2.  Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial.

Authors:  J M Middeke; R Herbst; S Parmentier; G Bug; M Hänel; G Stuhler; K Schäfer-Eckart; W Rösler; S Klein; W Bethge; U Bitz; B Büttner; H Knoth; N Alakel; M Schaich; A Morgner; M Kramer; K Sockel; M von Bonin; F Stölzel; U Platzbecker; C Röllig; C Thiede; G Ehninger; M Bornhäuser; J Schetelig
Journal:  Leukemia       Date:  2015-08-18       Impact factor: 11.528

3.  Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT.

Authors:  Maria H Gilleece; Avichai Shimoni; Myriam Labopin; Stephen Robinson; Dietrich Beelen; Gerard Socié; Ali Unal; Arnold Ganser; Antonin Vitek; Henrik Sengeloev; Ibrahim Yakoub-Agha; Eleni Tholouli; Emmanuelle Polge; Mohamad Mohty; Arnon Nagler
Journal:  Blood Cancer J       Date:  2021-05-12       Impact factor: 11.037
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.